Tongzu Heya Rixianbaier

Tongzu Heya Rixianbaier is a Traditional Uighur Medicine (TUM) developed by Xinjiang Yindolan Pharmaceutical in collaboration with the Beijing University of Chinese Medicine. Formulated as an oral tablet, it is primarily indicated for the treatment of constipation, specifically the "abnormal savda" (black bile) humor type as defined in Uighur medical theory. The drug is currently undergoing clinical evaluation (e.g., trial CTR20244963) to establish its efficacy, safety, and optimal dosing for patients suffering from chronic constipation. As a traditional botanical formulation, it likely utilizes a multi-component approach to regulate gastrointestinal motility and balance humors.

Brand names

RixianbaierTongzu Heya Rixianbaier

Other names

Tongzu Heya Rixianbaier tablet通阻合雅日先白尔片